%0 Journal Article %A Leif Karlsson %A Michela Barbaro %A Ewoud Ewing %A David Gomez-Cabrero %A Svetlana Lajic %T Genome-wide investigation of DNA methylation in congenital adrenal hyperplasia %D 2020 %R 10.1101/19008524 %J medRxiv %P 19008524 %X Background Patients with congenital adrenal hyperplasia (CAH) are at risk of long-term cognitive and metabolic sequelae with some of the effects being attributed to the chronic glucocorticoid treatment that they receive. This study investigates genome-wide DNA methylation in patients with CAH to determine whether there is evidence for epigenomic reprogramming as well as any relationship to patient outcome.Methods We analysed CD4+ T cell DNA from 28 patients with CAH (mean age=18.5 ±6.5 years [y]) and 37 population controls (mean age=17.0 ±6.1 y) with the Infinium-HumanMethylation450 BeadChip array to measure genome-wide locus-specific DNA methylation levels. Effects of CAH, phenotype and CYP21A2 genotype on methylation were investigated as well as the association between differentially methylated CpGs, glucose homeostasis, blood lipid profile and cognitive functions. In addition, we report data on a small cohort of 11 patients (mean age=19.1, ±6.0 y) with CAH who were treated prenatally with dexamethasone (DEX) in addition to postnatal glucocorticoid treatment.Results We identified two CpGs to be associated with patient phenotype: cg18486102 (located in the FAIM2 gene; rho=0.58, adjusted p=0.027) and cg02404636 (located in the SFI1 gene; rho=0.58, adjusted p=0.038). cg02404636 was also associated with genotype (rho=0.59, adjusted p=0.024). Higher levels of serum C-peptide was also observed in patients with CAH (p=0.044). Additionally, levels of C-peptide and HbA1c were positively correlated with patient phenotype (p=0.044 and p=0.034) and genotype (p=0.044 and p=0.033), respectively. No significant association was found between FAIM2 methylation and cognitive or metabolic outcome. However, SFI1 TSS methylation was associated with fasting plasma HDL cholesterol levels (p=0.035).Conclusion In conclusion, higher methylation levels in CpG sites covering FAIM2 and SFI1 were associated with disease severity. Hypermethylation in these genes may have implications for long-term cognitive and metabolic outcome in patients with CAH.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Marianne and Marcus Wallenberg Foundation, International Fund Congenital Adrenal Hyperplasia (IFCAH)/European Society for Pediatric Endocrinology (ESPE), Stockholm County Council (ALF-SLL), Stiftelsen Frimurare Barnhuset i Stockholm (SFBS), Svenska Läkaresällskapet, Stiftelsen Samariten, Jerringfonden, Sällskapet Barnavård and Wera Ekströms Stiftelse för pediatrisk forskning.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Yesall data are available upon requestCAHcongenital adrenal hyperplasiaSW CAHsalt-wastingSV CAHsimple virilizingDEXdexamethasoneNCnon-classicGCglucocorticoidBbloodPplasmaSserumHDLhigh density lipoproteinLDLlow density lipoproteinWISCWechsler Intelligence Scale for ChildrenWAISWechsler Adult Intelligence ScalePBMCperipheral blood mononuclear cellsMACSmagnetic activated cell sorting450K arrayIllumina Infinium Human Methylation450 BeadChip ArraySNPsingle nucleotide polymorphismFDRfalse discovery rateTSStranscriptional start site. %U https://www.medrxiv.org/content/medrxiv/early/2020/02/10/19008524.full.pdf